SPON2 and cancer: To investigate cancer-induced changes in SPON2 expression, a pyrosequencing assay was designed for SPON2 covering 117 bp spanning 7 CpG sites, including 1 CpG site identified by the Illumina 450k array (Figure 4E and F).